Form 4: Life360 Director Sells Over $250K in Company Stock

Life360 Director James Synge reported the sale of 3,966 shares of common stock for approximately $253,548.

Summary

• James Synge, a Director of Life360, Inc. (LIF), reported the sale of 3,966 shares of the company's common stock.
• The transactions occurred on December 16, 2025, and were executed under a Rule 10b5-1 plan.
• The shares were sold in two separate transactions: 2,448 shares at a weighted average price of $63.63 per share, and 1,518 shares at a weighted average price of $64.49 per share.
• The total value of the shares sold amounts to approximately $253,548.06.
• These shares were held indirectly by ICCA Labs, LLC, where the Reporting Person has shared investment control over Carthona Capital FS Pty Ltd., a member of ICCA Labs, LLC.
• Following these transactions, James Synge beneficially owns 194,754 shares of Life360 common stock directly.
• The remaining beneficial ownership includes common stock, Chess Depositary Interests (CDIs) converted at a 1:3 ratio, and 1,405 restricted stock units.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a director selling shares, which can sometimes be interpreted as a lack of confidence, despite the transaction being pre-planned under a 10b5-1 plan.

Negatives

• A director selling a significant number of shares, even if pre-planned, can sometimes be perceived negatively by investors as it may suggest a lack of confidence in the company's near-term prospects or valuation.

Future Outlook

NA

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. Insider sales are a routine part of market activity, often pre-scheduled, but can be scrutinized by investors for potential signals about company performance or valuation.

Stakeholder Impact

• Shareholders may interpret the director's sale of shares as a signal, potentially influencing their perception of the company's current valuation or future prospects.

Key Dates

Keywords

Life360, LIF, Insider Transaction, Form 4, Director Stock Sale, Common Stock, SEC Filing, 10b5-1 Plan